Gynecologic Oncology Group: all 188 studies

Page 2 of 2. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Pemetrexed Disodium in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00087100Phase 2
• Pemetrexed Disodium in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00087087Phase 2
• Cetuximab and Carboplatin in Treating Patients With Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00086892Phase 2
• Docetaxel in Treating Patients With Recurrent or Persistent Endometrial Carcinoma (Cancer)CompletedNCT00085332Phase 2
• Paclitaxel and Celecoxib in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal CancerTerminatedNCT00084448Phase 2
• Oxaliplatin in Treating Patients With Persistent or Recurrent Endometrial CancerCompletedNCT00071929Phase 2
• Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical CancerCompletedNCT00068549Phase 1
• Radiation Therapy to the Abdomen Plus Docetaxel in Treating Patients With Recurrent or Persistent Advanced Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00066456Phase 1
• Polyglutamate Paclitaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Peritoneal, or Fallopian Tube CancerCompletedNCT00060359Phase 1
• Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for CancerCompletedNCT00058071Phase 3
• Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical CancerCompletedNCT00054444Phase 1
• Karenitecin in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00054119Phase 2
• Chemotherapy and Radiation Therapy With or Without Surgery in Treating Patients With Stage I Cancer of the CervixTerminatedNCT00054067Phase 3
• Vaginal Changes and Sexual Function in Patients With Cervical CancerCompletedNCT00053261
• Research Study in Patients With Advanced Ovarian Epithelial CancerWithdrawnNCT00053235
• EF5 to Detect Tumor Hypoxia in Patients With Stage IIB, Stage IIIB, or Stage IVA Cervical CancerCompletedNCT00049231Not applicable
• CT-2103 in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00045682Phase 2
• Docetaxel in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00041093Phase 2
• Capecitabine in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00039442Phase 2
• Combination Chemotherapy Plus Sargramostim in Treating Patients With Cancer of the UterusTerminatedNCT00033644Phase 2
• Combination Chemotherapy and Filgrastim or Pegfilgrastim in Treating Patients With Recurrent or Persistent Cancer of the UterusCompletedNCT00031629Phase 2
• Liposomal Doxorubicin in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00030472Phase 2
• Fibrin Sealant in Decreasing Lymphedema Following Surgery to Remove Lymph Nodes in Patients With Cancer of the VulvaCompletedNCT00028951Phase 3
• SU5416 in Treating Patients With Persistent or Recurrent Cervical CancerCompletedNCT00026260Phase 2
• Paclitaxel in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal CancerTerminatedNCT00023907Phase 2
• Flavopiridol in Treating Patients With Recurrent or Persistent Endometrial CancerCompletedNCT00023894Phase 2
• Gefitinib in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00023699Phase 2
• Tirapazamine Plus Cisplatin in Treating Patients With Persistent or Recurrent Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00020696Phase 2
• Fenretinide Followed by Surgery Compared With Surgery Alone in Preventing Ovarian Cancer in Patients at Increased RiskTerminatedNCT00017134Not applicable
• Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and AnemiaCompletedNCT00017004Phase 3
• Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical CancerCompletedNCT00016926Phase 2
• Combination Chemotherapy Compared With Hormone Therapy in Treating Patients With Recurrent, Stage III, or Stage IV Endometrial CancerTerminatedNCT00016341Phase 3
• Capecitabine in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cavity CancerTerminatedNCT00006812Phase 2
• Gemcitabine and Cisplatin in Treating Patients With Refractory or Recurrent Cancer of the CervixTerminatedNCT00006482Phase 2
• Nitrocamptothecin in Treating Patients With Recurrent or Metastatic Ovarian Epithelial or Primary Peritoneal CancerWithdrawnNCT00006267Phase 2
• Liposomal Doxorubicin and Carboplatin in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00006235Phase 1
• Gemcitabine in Treating Patients With Persistent or Recurrent Cancer of the CervixTerminatedNCT00006224Phase 2
• Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the VulvaTerminatedNCT00006096Phase 3
• Gemcitabine Plus Cisplatin in Treating Patients With Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Is Recurrent or Has Not Responded to Platinum-based ChemotherapyCompletedNCT00006028Phase 2
• Liposomal Doxorubicin in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNCT00005861Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00005840Phase 1
• Oxaliplatin in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNCT00005837Phase 2
• Oxaliplatin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Peritoneal Cancer That Has Not Responded to Platinum- Based ChemotherapyCompletedNCT00005836Phase 2
• Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial CancerCompletedNCT00005830Phase 1
• Chemotherapy in Treating Patients With Sarcoma of the UterusCompletedNCT00005643Phase 2
• Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian or Primary Peritoneal CancerCompletedNCT00005046Phase 1
• Irofulven in Treating Patients With Persistent or Recurrent, Refractory Endometrial CancerCompletedNCT00005031Phase 2
• Topotecan in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal CancerTerminatedNCT00005029Phase 2
• Combination Chemotherapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Primary Peritoneal CancerCompletedNCT00005026Phase 1
• Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III Ovarian CancerTerminatedNCT00004221Phase 2
• Docetaxel in Treating Patients With Recurrent or Refractory Ovarian or Primary Peritoneal CancerTerminatedNCT00004037Phase 2
• Topotecan Plus Etoposide in Treating Patients With Recurrent Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00003967Phase 1
• Danazol in Treating Patients With Advanced or Recurrent Endometrial CancerCompletedNCT00003946Phase 2
• Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical CancerCompletedNCT00003945Phase 3
• Quality of Life in Survivors of Gynecologic CancerCompletedNCT00003795
• Quality-of-Life Study of Patients With Previously Treated Ovarian CancerTerminatedNCT00003794
• Combination Chemotherapy With or Without G-CSF in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial CancerCompletedNCT00003691Phase 3
• Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic NeoplasiaCompletedNCT00003688Phase 2
• Amifostine in Treating Women With Ovarian, Peritoneal, Cervical, Fallopian Tube, Uterine, or Endometrial CancerTerminatedNCT00003624Phase 2
• Aminocamptothecin in Treating Patients With Recurrent or Refractory Ovarian Epithelial Cancer or Primary Cancer of the PeritoneumCompletedNCT00003523Phase 2
• Vaccine Therapy in Treating Patients With Stage III or Stage IV Ovarian Epithelial CancerTerminatedNCT00003386Phase 2
• Combination Chemotherapy in Treating Patients With Untreated Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00003385Phase 1
• Protein Expression as a Potential Diagnostic Biomarker of Cervical Dysplasia and/or CancerCompletedNCT00003384Not applicable
• Combination Chemotherapy Consisting of Gemcitabine And Topotecan in Treating Patients With Refractory or Recurrent Ovarian or Fallopian Tube CancerTerminatedNCT00003382Phase 1
• Liposomal Doxorubicin and Etoposide in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Peritoneal CancerTerminatedNCT00003380Phase 1
• Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical CancerCompletedNCT00003379Phase 1/2
• Combination Chemotherapy in Treating Patients With Previously Untreated Stage III or Stage IV Ovarian or Primary Peritoneal CancerTerminatedNCT00003378Phase 1
• Lymphatic Mapping in Treating Patients With Stage I or Stage II Cancer of the VulvaCompletedNCT00003325Phase 3
• Combination Chemotherapy in Treating Patients With Primary Peritoneal or Stage III Epithelial Ovarian CancerCompletedNCT00003322Phase 3
• Gemcitabine in Treating Patients With Recurrent or Refractory Cancer of the UterusTerminatedNCT00003316Phase 2
• Surgery Plus Medroxyprogesterone in Preventing Endometrial CancerTerminatedNCT00003179Phase 2
• Topotecan in Treating Patients With Recurrent or Refractory Cancer of the UterusTerminatedNCT00003156Phase 2
• Ifosfamide With or Without Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cancer of the UterusCompletedNCT00003128Phase 3
• Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the CervixCompletedNCT00003078Phase 3
• Paclitaxel in Treating Patients With Recurrent or Persistent Cancer of the UterusTerminatedNCT00003054Phase 2
• Combination Chemotherapy in Treating Patients With Recurrent or Advanced Cancer of the UterusTerminatedNCT00002993Phase 2
• Estrogen Replacement Therapy in Treating Women With Early-Stage Endometrial CancerTerminatedNCT00002976Phase 3
• Chemotherapy With or Without Peripheral Stem Cell Transplantation in Treating Patients With Persistent Ovarian Epithelial CancerTerminatedNCT00002819Phase 3
• Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical CancerCompletedNCT00002813Phase 2
• Paclitaxel and Cisplatin in Treating Patients With Stage III or Stage IV Ovarian Cancer or Primary Peritoneal CancerCompletedNCT00002717Phase 3
• Laparoscopic Surgery or Standard Surgery in Treating Patients With Endometrial Cancer or Cancer of the UterusCompletedNCT00002706Phase 3
• Combination Chemotherapy With or Without Surgery in Treating Patients With Stage III Ovarian Epithelial CancerCompletedNCT00002568Phase 3
• Paclitaxel in Treating Patients With Advanced, Refractory, or Recurrent Cervical or Vaginal CancerCompletedNCT00002562Phase 2
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Cancer of the UterusCompletedNCT00002546Phase 3
• Laparoscopic Staging in Patients With Ovarian, Fallopian Tube, or Other Primary Abdominal CancersCompletedNCT00002538Phase 2
• Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical CancerCompletedNCT00002536Phase 3
• Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial CancerCompletedNCT00002493Phase 3
• Etoposide in Treating Patients With Advanced Ovarian or Cervical CancerTerminatedNCT00002478Phase 2

← Gynecologic Oncology Group overview and focus areas